NBI 30775 (R121919), an orally active antagonist of the corticotropin‐releasing factor (CRF) type‐1 receptor for the treatment of anxiety and depression
Year: 2005
Type: article
Source: Drug Development Research
DOI: 10.1002/ddr.20025
Authors: Chen Chen, Dimitri E. Grigoriadis
Institution: Neurocrine Biosciences (United States)
Language: English
Subfield: Behavioral Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2017622236
